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Bio-Medical
A cytometer now under development
exploits spatial sorting of sampled cells
on a microarray chip followed by use of
grating-coupled surface-plasmon-reso-
nance imaging (GCSPRI) to detect the
sorted cells. This cytometer on a chip is
a prototype of contemplated future
miniature cytometers that would be suit-
able for rapidly identifying pathogens
and other cells of interest in both field
and laboratory applications and that
would be attractive as alternatives to con-
ventional flow cytometers.
The basic principle of operation of a
conventional flow cytometer requires
fluorescent labeling of sampled cells,
stringent optical alignment of a laser
beam with a narrow orifice, and flow of
the cells through the orifice, which is
subject to clogging. In contrast, the prin-
ciple of operation of the present cytome-
ter on a chip does not require fluores-
cent labeling of cells, stringent optical
alignment, or flow through a narrow ori-
fice. The basic principle of operation of
the cytometer on a chip also reduces the
complexity, mass, and power of the asso-
ciated laser and detection systems, rela-
tive to those needed in conventional
flow cytometry.
Instead of making cells flow in single
file through a narrow flow orifice for se-
quential interrogation as in conven-
tional flow cytometry, a liquid contain-
ing suspended sampled cells is made to
flow over the front surface of a microar-
ray chip on which there are many cap-
ture spots. Each capture spot is coated
with a thin (≈50-nm) layer of gold that is,
in turn, coated with antibodies that bind
to cell-surface molecules characteristic
of the cell species of interest. The multi-
plicity of capture spots makes it possible
to perform rapid, massively parallel
analysis of a large cell population.
The binding of cells to each capture
spot gives rise to a minute change in the
index of refraction at the surface of the
chip. This change in the index of refrac-
tion is what is sensed in GCSPRI, as de-
scribed briefly below. The identities of
the various species in a sample of cells is
spatially encoded in the chip by the pat-
tern of capture spots. The number of
cells of a particular species is deter-
mined from the magnitude of the GC-
SPRI signal from that spot.
GCSPRI as used here can be summa-
rized as follows: The cytometer chip is
fabricated with a diffraction grating on
its front surface. The chip is illumi-
nated with a light emitting diode (LED)
from the front. By proper choice of
grating parameters and of the wave-
length and the angle of incidence of a
laser beam, laser light can be made to
be coupled into an electromagnetic
mode that resonates with surface plas-
mons and thus couples light into sur-
face plasmons. Coupling of light into a
surface plasmon at a given location re-
duces the amount of incident light re-
flected from that location. A change in
the index of refraction at the surface of
a capture spot gives rise to a change in
the resonance condition. Depending
on the specific design, the change in
the index of refraction could manifest
itself as a brightening or darkening, a
change in the wavelength needed to ex-
cite the plasmon at a given angle of in-
cidence, or a change in the angle of in-
cidence needed to excite the plasmon
at a given wavelength.
Whereas a multiwavelength laser sys-
tem with multichannel detection would
be needed to detect multiple species in
conventional flow cytometry, it suffices
to use an LED and a single detector
channel in the GCSPRI approach: this
contributes significantly to reductions in
cost, complexity, size, mass, and power.
GCSPRI cytometer chips could be made
of plastic and could be mass-produced
cheaply by use of molding and other
methods adopted from the manufacture
of digital video disks. These methods are
amenable to a high degree of miniatur-
ization: such additional features as flu-
idic channels, reaction chambers, and
fluid-coupling ports could readily be in-
corporated into the chips, without incur-
ring substantial additional costs.
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The principle of tissue microfluidics
and its resultant techniques has been ap-
plied to cell analysis. Building microflu-
idics to suit a particular tissue sample
would allow the rapid, reliable, inexpen-
sive, highly parallelized, selective extrac-
tion of chosen regions of tissue for pur-
poses of further biochemical analysis.
Furthermore, the applicability of the
techniques ranges beyond the described
pathology application. For example, they
would also allow the posing and success-
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ful answering of new sets of questions in
many areas of fundamental research. 
The proposed integration of microflu-
idic techniques and tissue slice samples is
called “tissue microfluidics” because it
molds the microfluidic architectures in
accordance with each particular structure
of each specific tissue sample. Thus, mi-
crofluidics can be built around the tissues,
following the tissue structure, or alterna-
tively, the microfluidics can be adapted to
the specific geometry of particular tissues.
By contrast, the traditional approach is
that microfluidic devices are structured in
accordance with engineering considera-
tions, while the biological components in
applied devices are forced to comply with
these engineering presets. 
The proposed principles represent a
paradigm shift in microfluidic technol-
ogy in three important ways: 
• Microfluidic devices are to be directly
integrated with, onto, or around tissue
samples, in contrast to the conven-
tional method of off-chip sample ex-
traction followed by sample insertion
in microfluidic devices. 
• Architectural and operational principles
of microfluidic devices are to be subor-
dinated to suit specific tissue structure
and needs, in contrast to the conven-
tional method of building devices ac-
cording to fluidic function alone and
without regard to tissue structure. 
• Sample acquisition from tissue is to be
performed on-chip and is to be inte-
grated with the diagnostic measurement
within the same device, in contrast to
the conventional method of off-chip
sample prep and subsequent insertion
into a diagnostic device. A more ad-
vanced form of tissue integration with
microfluidics is tissue encapsulation,
wherein the sample is completely encap-
sulated within a microfluidic device, to
allow for full surface access. 
The immediate applications of these
approaches lie with diagnostics of tissue
slices and biopsy samples — e.g. for can-
cer — but the approaches would also be
very useful in comparative genomics and
other areas of fundamental research in-
volving heterogeneous tissue samples. 
The approach advocates and utilizes the
bottom-up customization of microfluidic
architectures to biosamples, in contrast to
the traditional top-down approach of build-
ing the architectures first and then putting
the biosamples inside. Further, as particular
embodiments of the above principle, novel
techniques of sub-sample selection and iso-
lation are presented. These techniques
would have wide applicability in fundamen-
tal research and biomedical diagnostics. 
In particular, an in situ microfluidic
technique of single-cell isolation, or multi-
ple single-cell isolations, is described, and
is performed upon tissue sections at-
tached to pathology glass slides. The tech-
nique combines the advantages of preserv-
ing the architectural integrity of the tissue
section while allowing flexibility and preci-
sion of cell selection, rapid prototyping,
and enhanced sample purity, while bene-
fiting from the experience of the patholo-
gist in the selection process. The result is a
system that would allow the rapid and reli-
able biochemical analysis and diagnosis of
pathologic processes with sensitivity ex-
tended down to the level of even a single
cell, with high levels of confidence in the
diagnostic determination. 
These techniques would allow the ex-
traction of cells and cell nuclei chosen for
their potentially pathologic origin, e.g.
cancer. The chief advantages of the pro-
posed methods are their speed, ease, reli-
ability, and capacity to select individual
cells from a tissue slice population with a
higher degree of purity and specificity.
The result is the extracted DNA can be
biochemically analyzed with a higher de-
gree of diagnostic accuracy, as the iso-
lated sub-sample would not be diluted by
unwanted material from the ambient tis-
sue. In comparison to other techniques,
the proposed methods would combine
high specificity with high speed. 
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